Editorial: is it not just PROs, but the most important individual PRO, that really matters in Crohn’s disease?

Karla Cameron; Miles P. Sparrow

doi:10.1111/apt.16843

Editorial: is it not just PROs, but the most important individual PRO, that really matters in Crohn’s disease?

Research output: Contribution to journal › Editorial › Other › peer-review

Original language	English
Pages (from-to)	1038-1039
Number of pages	2
Journal	Alimentary Pharmacology & Therapeutics
Volume	55
Issue number	8
DOIs	https://doi.org/10.1111/apt.16843
Publication status	Published - Apr 2022
Externally published	Yes

Access to Document

10.1111/apt.16843

Cite this

@article{d8315af5833342d8874265942f237766,

title = "Editorial: is it not just PROs, but the most important individual PRO, that really matters in Crohn{\textquoteright}s disease?",

author = "Karla Cameron and Sparrow, {Miles P.}",

note = "Funding Information: Karla Cameron ‐ nothing to declare; Miles Sparrow has received educational grants or research support from Ferring, Orphan and Gilead, speakers fees from Janssen, Abbvie, Ferring, Takeda, Pfizer and Shire and has served on advisory boards for Janssen, Takeda, Pfizer, Celgene, Abbvie, MSD, Emerge Health, Gilead and BMS. ",

year = "2022",

month = apr,

doi = "10.1111/apt.16843",

language = "English",

volume = "55",

pages = "1038--1039",

journal = "Alimentary Pharmacology & Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell",

number = "8",

}

TY - JOUR

T1 - Editorial

T2 - is it not just PROs, but the most important individual PRO, that really matters in Crohn’s disease?

AU - Cameron, Karla

AU - Sparrow, Miles P.

N1 - Funding Information: Karla Cameron ‐ nothing to declare; Miles Sparrow has received educational grants or research support from Ferring, Orphan and Gilead, speakers fees from Janssen, Abbvie, Ferring, Takeda, Pfizer and Shire and has served on advisory boards for Janssen, Takeda, Pfizer, Celgene, Abbvie, MSD, Emerge Health, Gilead and BMS.

PY - 2022/4

Y1 - 2022/4

UR - http://www.scopus.com/inward/record.url?scp=85127422866&partnerID=8YFLogxK

U2 - 10.1111/apt.16843

DO - 10.1111/apt.16843

M3 - Editorial

C2 - 35362139

AN - SCOPUS:85127422866

SN - 0269-2813

VL - 55

SP - 1038

EP - 1039

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

IS - 8

ER -

Editorial: is it not just PROs, but the most important individual PRO, that really matters in Crohn’s disease?

Access to Document

Other files and links

Cite this